文献速递心力衰竭与心肌病心律失常

肥厚型心肌病收缩功能保留患者的晚期钆增强预后价值

Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function.
PubMed 文献 · J Am Coll Cardiol · 2018-01-01

该研究纳入1,423例低/中危、左室射血分数保留的成人肥厚型心肌病患者,评估心脏磁共振晚期钆增强(LGE)的增量预后价值。随访4.7±2.0年,60例(4%)发生复合终点;LGE≥15%与复合终点风险升高相关,在梗阻亚组中风险比为3.04,且LGE和心肌切除术可改善5年心脏性猝死风险评分的预测效能。

要点

  • LGE≥15%与肥厚型心肌病患者复合终点风险升高独立相关。
  • 在梗阻亚组中,LGE≥15%的亚风险比为3.04(95%CI 1.48-6.10)。
  • 将LGE≥15%和心肌切除术加入5年SCD风险评分可改善模型拟合。

核心结论

  • 在收缩功能保留的低/中危成人肥厚型心肌病患者中,LGE百分比与复合终点发生率显著相关,提供增量预后价值。

研究设计与样本

  • 连续纳入1,423例低/中危、左室射血分数保留的成人肥厚型心肌病患者(平均年龄66±14岁,60%男性),2008年1月至2015年12月在本中心接受经胸超声心动图和心脏磁共振检查。

主要发现

  • 平均5年SCD风险评分为2.3±2.0,平均最大左室流出道压差为70±55 mm Hg(中位数74 mm Hg,IQR 10-67), indexed LV mass为91±10 g/m2,LGE为8.4±12%(IQR 0%-19%),50%患者存在LGE。
  • 随访4.7±2.0年,60例(4%)达到复合终点。
  • 二次样条分析显示LGE≥15%与复合事件风险增加相关。
  • 在梗阻亚组中,竞争风险回归显示LGE≥15%与复合终点发生率较高相关(亚风险比3.04,95%CI 1.48-6.10),心肌切除术与较低发生率相关(亚风险比0.44,95%CI 0.20-0.76),均p<0.01。
  • 将LGE≥15%和心肌切除术序贯加入5年SCD风险评分,对数似然比从-227.85改善至-219.14(卡方17)和-215.14(卡方8),均p<0.01;LGE百分比与复合事件的关联在心肌切除术和非梗阻亚组中相似。

关键数值与推荐

  • LGE≥15%被确定为与复合终点风险增加相关的阈值。
  • 梗阻亚组中LGE≥15%的亚风险比为3.04(95%CI 1.48-6.10),心肌切除术的亚风险比为0.44(95%CI 0.20-0.76)。

临床怎么用

  • 对于收缩功能保留的低/中危肥厚型心肌病患者,可考虑将LGE百分比(尤其≥15%)纳入风险分层,以辅助识别复合终点高风险患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A high proportion of patients with hypertrophic cardiomyopathy (HCM) have evidence of late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR). OBJECTIVES: This study sought to assess the incremental prognostic utility of LGE in patients with HCM. METHODS: We studied 1,423 consecutive low-/intermediate-risk patients with HCM (age ≥18 years) with preserved left ventricular (LV) ejection fraction (mean age 66 ± 14 years, 60% men) who underwent transthoracic echocardiography (TTE) (including dimensions and LV outflow tract gradients) and CMR (including LGE as a % of LV mass) at our center between January 2008 and December 2015. The primary composite endpoint was sudden cardiac death (SCD) and appropriate implantable cardioverter-defibrillator discharge. The percent 5-year SCD risk score was calculated. RESULTS: The mean 5-year SCD risk score was 2.3 ± 2.0. Mean maximal LV outflow tract gradient (TTE) was 70 ± 55 mm Hg (median 74 mm Hg [interquartile range (IQR): 10 to 67 mm Hg]); indexed LV mass and LGE (both on CMR) were 91 ± 10 g/m2 and 8.4 ± 12% (IQR: 0% to 19%); 50% had LGE on CMR. Of these, 458 were nonobstructive and 965 were obstructive (of which 686 were underwent myectomy). At 4.7 ± 2.0 years of follow-up, 60 (4%) met the composite endpoint. On quadratic spline analysis, LGE ≥15% was associated with increased risk of composite events. In the obstructive subgroup, on competing risk regression analysis, ≥15% LGE (subhazard ratio: 3.04 [95% confidence interval: 1.48 to 6.10]) was associated with a higher rate and myectomy (subhazard ratio: 0.44 [95% confidence interval: 0.20 to 0.76]) was associated with a lower rate of composite endpoints (both p < 0.01). Similarly, sequential addition of LGE ≥15% and myectomy to % 5-year SCD risk score improved the log likelihood ratios from -227.85 to -219.14 (chi-square 17) and to -215.14 (chi-square 8; both p < 0.01). Association of %LGE with composite events was similar even in myectomy and nonobstructive subgroups. CONCLUSIONS: In low-/intermediate-risk adult patients with HCM (obstructive, myectomy, and nonobstructive subgroups) with preserved systolic function, %LGE was significantly associated with a higher rate of composite endpoint, providing incremental prognostic utility.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Mentias A, Raeisi-Giglou P, Smedira NG, et al. Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Preserved Systolic Function. J Am Coll Cardiol. 2018. PMID: 30115224. doi:10.1016/j.jacc.2018.05.060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。